Cite
MLA Citation
Riad Salem et al.. “Characterization of response to atezolizumab + bevacizumab versus sorafenib for hepatocellular carcinoma: Results from the IMbrave150 trial.” Cancer medicine, vol. 10, 2021, pp. 5437–5447. http://access.bl.uk/ark:/81055/vdc_100140195640.0x000017